相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Characterization of Near Full-Length Transmitted/Founder HIV-1 Subtype D and A/D Recombinant Genomes in a Heterosexual Ugandan Population (2006-2011)
Sheila N. Balinda et al.
VIRUSES-BASEL (2022)
Cohort Profile: IAVI's HIV epidemiology and early infection cohort studies in Africa to support vaccine discovery
Matt A. Price et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2021)
Breadth of CD8 T-cell mediated inhibition of replication of diverse HIV-1 transmitted-founder isolates correlates with the breadth of recognition within a comprehensive HIV-1 Gag, Nef, Env and Pol potential T-cell epitope (PTE) peptide set
Peter Hayes et al.
PLOS ONE (2021)
A Novel Sample Selection Approach to Aid the Identification of Factors That Correlate With the Control of HIV-1 Infection
Julia Makinde et al.
FRONTIERS IN IMMUNOLOGY (2021)
Utilizing Computational Machine Learning Tools to Understand Immunogenic Breadth in the Context of a CD8 T-Cell Mediated HIV Response
Ed McGowan et al.
FRONTIERS IN IMMUNOLOGY (2021)
Increased Frequency of Inter-Subtype HIV-1 Recombinants Identified by Near Full-Length Virus Sequencing in Rwandan Acute Transmission Cohorts
Gisele Umviligihozo et al.
FRONTIERS IN MICROBIOLOGY (2021)
Comprehensive epitope mapping using polyclonally expanded human CD8 T cells and a two-step ELISpot assay for testing large peptide libraries
Clive M. Michelo et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2021)
The CD8+ T Cell Noncytotoxic Antiviral Responses
Maelig G. Morvan et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2021)
Direct identification of HLA-presented CD8 T cell epitopes from transmitted founder HIV-1 variants
Jonathan Hare et al.
PROTEOMICS (2021)
Sampling SARS-CoV-2 Proteomes for Predicted CD8 T-Cell Epitopes as a Tool for Understanding Immunogenic Breadth and Rational Vaccine Design
Jonathan Hare et al.
FRONTIERS IN BIOINFORMATICS (2021)
T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titers
Prabhu S. Arunachalam et al.
NATURE MEDICINE (2020)
Infection with multiple HIV-1 founder variants is associated with lower viral replicative capacity, faster CD4+T cell decline and increased immune activation during acute infection
Gladys N. Macharia et al.
PLOS PATHOGENS (2020)
CD8+ T cells in HIV control, cure and prevention
David R. Collins et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Control of the HIV-1 Load Varies by Viral Subtype in a Large Cohort of African Adults With Incident HIV-1 Infection
Matt A. Price et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
Longitudinal bioluminescent imaging of HIV-1 infection during antiretroviral therapy and treatment interruption in humanized mice
John D. Ventura et al.
PLOS PATHOGENS (2019)
Incomplete Downregulation of CD4 Expression Affects HIV-1 Env Conformation and Antibody-Dependent Cellular Cytotoxicity Responses
Jeremie Prevost et al.
JOURNAL OF VIROLOGY (2018)
Neutralization tiers of HIV-1
David C. Montefiori et al.
CURRENT OPINION IN HIV AND AIDS (2018)
Identification and specificity of broadly neutralizing antibodies against HIV
Laura E. McCoy et al.
IMMUNOLOGICAL REVIEWS (2017)
Adenovirus-based HIV-1 vaccine candidates tested in efficacy trials elicit CD8+ T cells with limited breadth of HIV-1 inhibition
Peter J. Hayes et al.
AIDS (2016)
Control of HIV-1 replication in vitro by vaccine-induced human CDS+ T cells through conserved subdominant Pol epitopes
Tina Ahmed et al.
VACCINE (2016)
Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus
Damien C. Tully et al.
PLOS PATHOGENS (2016)
Broad HIV-1 inhibition in vitro by vaccine-elicited CD8(+) T cells in African adults
Gaudensia Mutua et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2016)
Optimized Replicating Renilla Luciferase Reporter HIV-1 Utilizing Novel Internal Ribosome Entry Site Elements for Native Nef Expression and Function
Michael O. Alberti et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2015)
Multiplexed highly-accurate DNA sequencing of closely-related HIV-1 variants using continuous long reads from single molecule, real-time sequencing
Dario A. Dilernia et al.
NUCLEIC ACIDS RESEARCH (2015)
Heterosexual Transmission of Subtype C HIV-1 Selects Consensus-Like Variants without Increased Replicative Capacity or Interferon-α Resistance
Martin J. Deymier et al.
PLOS PATHOGENS (2015)
Cooperation of B Cell Lineages in Induction of HIV-1-Broadly Neutralizing Antibodies
Feng Gao et al.
CELL (2014)
Measuring inhibition of HIV replication by ex vivo CD8+ T cells
Chloe K. Slichter et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2014)
Development of a luciferase based viral inhibition assay to evaluate vaccine induced CD8 T-cell responses
Marloes A. Naarding et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2014)
Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1
Marcella Sarzotti-Kelsoe et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2014)
Global Panel of HIV-1 Env Reference Strains for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies
Allan deCamp et al.
JOURNAL OF VIROLOGY (2014)
Broad HIV Epitope Specificity and Viral Inhibition Induced by Multigenic HIV-1 Adenovirus Subtype 35 Vector Vaccine in Healthy Uninfected Adults
Jakub Kopycinski et al.
PLOS ONE (2014)
Selection bias at the heterosexual HIV-1 transmission bottleneck
Jonathan M. Carlson et al.
SCIENCE (2014)
Particle infectivity of HIV-1 full-length genome infectious molecular clones in a subtype C heterosexual transmission pair following high fidelity amplification and unbiased cloning
Martin J. Deymier et al.
VIROLOGY (2014)
Vaccine-Induced Gag-Specific T Cells Are Associated With Reduced Viremia After HIV-1 Infection
Holly Janes et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine
Scott M. Hammer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Molecular identification, cloning and characterization of transmitted/founder HIV-1 subtype A, D and A/D infectious molecular clones
Joshua Baalwa et al.
VIROLOGY (2013)
A Blueprint for HIV Vaccine Discovery
Dennis R. Burton et al.
CELL HOST & MICROBE (2012)
Antiviral Inhibitory Capacity of CD8+ T cells Predicts the Rate of CD4+ T-Cell Decline in HIV-1 Infection
Hongbing Yang et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Generation of Transmitted/Founder HIV-1 Infectious Molecular Clones and Characterization of Their Replication Capacity in CD4 T Lymphocytes and Monocyte-Derived Macrophages
Christina Ochsenbauer et al.
JOURNAL OF VIROLOGY (2012)
International Technology Transfer of a GCLP-Compliant HIV-1 Neutralizing Antibody Assay for Human Clinical Trials
Daniel A. Ozaki et al.
PLOS ONE (2012)
MRKAd5 HIV-1 Gag/Pol/Nef Vaccine-Induced T-Cell Responses Inadequately Predict Distance of Breakthrough HIV-1 Sequences to the Vaccine or Viral Load
Holly Janes et al.
PLOS ONE (2012)
A Phase I Double Blind, Placebo-Controlled, Randomized Study of a Multigenic HIV-1 Adenovirus Subtype 35 Vector Vaccine in Healthy Uninfected Adults
Michael C. Keefer et al.
PLOS ONE (2012)
Safety and efficacy of the HVTN 503/Phambili Study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2h study
Glenda E. Gray et al.
LANCET INFECTIOUS DISEASES (2011)
Induction of Immunity to Human Immunodeficiency Virus Type-1 by Vaccination
M. Juliana McElrath et al.
IMMUNITY (2010)
Viral Inhibition Assay: A CD8 T Cell Neutralization Assay for Use in Clinical Trials of HIV-1 Vaccine Candidates
Aggeliki Spentzou et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Replication competent molecular clones of HIV-1 expressing Renilla luciferase facilitate the analysis of antibody inhibition in PBMC
Tara G. Edmonds et al.
VIROLOGY (2010)
A Limited Number of Antibody Specificities Mediate Broad and Potent Serum Neutralization in Selected HIV-1 Infected Individuals
Laura M. Walker et al.
PLOS PATHOGENS (2010)
The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection
Nilu Goonetilleke et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection
Jesus F. Salazar-Gonzalez et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Human Immunodeficiency Virus Type 1 Elite Neutralizers: Individuals with Broad and Potent Neutralizing Activity Identified by Using a High-Throughput Neutralization Assay together with an Analytical Selection Algorithm
Melissa D. Simek et al.
JOURNAL OF VIROLOGY (2009)
Measuring HIV-1-specific T cell immunity: How valid are current assays?
M. Patricia D'Souza et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Cross-clade detection of HIV-1-specific cytotoxic T lymphocytes does not reflect cross-clade antiviral activity
Michael S. Bennett et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis
M. Juliana McElrath et al.
LANCET (2008)
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
Susan P. Buchbinder et al.
LANCET (2008)
Identification and characterisation of transmitted and early founder virus envelopes in primary HIV-1 infection
Brandon F. Keele et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Recognition of escape variants in ELISPOT does not always predict CD8(+) T-cell recognition of simian immunodeficiency virus-infected cells expressing the same variant sequences
Laura E. Valentine et al.
JOURNAL OF VIROLOGY (2008)
Autologous CD4/CD8 co-culture assay:: A physiologically-relevant composite measure of CD8+ T lymphocyte function in HIV-infected persons
Steven R. Fauce et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2007)
HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype
Asier Saez-Cirion et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Human immunodeficiency virus controllers: Mechanisms of durable virus control in the absence of antiretroviral therapy
Steven G. Deeks et al.
IMMUNITY (2007)
HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells
Michael R. Betts et al.
BLOOD (2006)
Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy
XP Wei et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
分享论文
